Ulla Wändel Liminga

In 1994, she started at the Medical Products Agency (MPA), Sweden, as a non-clinical assessor. She has since then worked with non-clinical as well as clinical efficacy and safety assessments.  In 2007, she became Scientific director pharmacology and toxicology at the MPA, and has from July 2012 been one of the Swedish members of the Pharmacovigilance Risk Assessment Committee (PRAC). She has a special interest and expertise in reproductive safety of medicines